Section III
31 – 40 of 6421
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Influence of marker-selection method in radiostereometric analysis of total knee arthroplasty on tibial baseplate migration patterns : a secondary analysis of a randomized controlled trial with 5-year follow-up
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
Diagnosis of external ventricular drainage related infections with real-time 16S PCR and third-generation 16S sequencing
2024) In Infectious Diseases(
- Contribution to journal › Article
-
Mark
Staphylococcus aureus bacteraemia, cardiac implantable electronic device, extraction, and the risk of recurrent infection; a retrospective population-based cohort study
2024) In Infectious Diseases(
- Contribution to journal › Article
-
Mark
Co-delivery of rhBMP-2 and zoledronic acid using calcium sulfate/hydroxyapatite carrier as a bioactive bone substitute to enhance and accelerate spinal fusion
(
- Contribution to journal › Article
-
Mark
Capillary leak syndrome was associated with more severe multisystem inflammatory syndrome in children during the COVID-19 pandemic
2024) In Acta Paediatrica, International Journal of Paediatrics(
- Contribution to journal › Article
-
Mark
Biomarkers and skin barrier function in atopic dermatitis and mycosis fungoides and Sézary syndrome
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
A joint venture : patients’ experiences with goal setting in rheumatology rehabilitation–a qualitative study
2024) In Disability and Rehabilitation(
- Contribution to journal › Article
-
Mark
From biochemical markers to molecular endotypes of osteoarthritis : a review on validated biomarkers
(
- Contribution to journal › Scientific review
-
Mark
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs : a Swedish nationwide study (COVID-19-REUMA)
2024) In Microbiology spectrum(
- Contribution to journal › Article